Federal award
NOVARTIS PHARMACEUTICALS CORPORATION
HT941026FE065
Contract
Obligated and Ceiling
- Obligated (net)
- $167,284.98
- Ceiling (potential value, not spending)
- $167,284.98
- Current value
- $167,284.98
- Gross positive obligations
- $167,284.98
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- NOVARTIS PHARMACEUTICALS CORPORATION · NG61ZA8TADW3
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- NOVARTIS SANIERUNGSSTIFTUNG · YE3YG1FDWMC5
- Awarding agency
- Department of Defense · sub-agency 97DH · office HT9410
- Funding agency
- Department of Defense · sub-agency 97DH
- Product or service (PSC)
- 6505 · DRUGS AND BIOLOGICALS
- Industry (NAICS)
- 325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
- PIID
- HT941026FE065
- Parent vehicle (IDV PIID)
- HT941026AE002
- Award type code
- A
- Actions
- 1 · Jun 18, 2026 to Jun 18, 2026
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History1
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jun 18, 2026 | FY2026 | 0 | — | $167,284.98 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.